𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant human interleukin-11 for treatment of chemotherapy-induced thrombocytopenia in patients with gastrointestinal cancer

✍ Scribed by Jie Li; Lin Shen; Yan Li; Xiaodong Zhang; Jian Li; Jifang Gong; Wei Deng

Publisher
Springer
Year
2007
Tongue
English
Weight
216 KB
Volume
6
Category
Article
ISSN
1610-1979

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacoeconomic analysis of oprelvekin
Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy
✍ Scott B. Cantor; Linda S. Elting; David V. Hudson Jr.; Edward B Rubenstein πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 315 KB

## Abstract ## BACKGROUND Previous research has shown oprelvekin (recombinant human interleukin‐11 [rhIL‐11]) to be effective in reducing the requirements for platelet transfusions after myelosuppressive chemotherapy in patients who have previously experienced thrombocytopenia. The economic conseq

Recombinant human interleukin-1 beta ana
Recombinant human interleukin-1 beta analogue as a regulator of hematopoiesis in patients receiving chemotherapy for urogenital cancers
✍ Tatsuo Iizumi; Satoshi Sato; Tetsuro Iiyama; Ryosuke Hata; Hiroshi Amemiya; Hiro πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 331 KB

Ten patients with advanced urologic cancers who were scheduled to receive at least two courses of chemotherapy were enrolled in this trial. Fifty thousand units of recombinant human interleukin-1 (IL-1) beta analogue Ltd., Tokyo, Japan) was administered subcutaneously only once or twice when severe